Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Dutasteride in Male Androgenetic Alopecia
NCT01831791Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dutasteride in androgenetic alopecia (AGA), sponsored by GSK. Started Apr 2013; status: completed.
02
Drugs
dutasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT01831791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01831791.